FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321597045> ?p ?o ?g. }

• W4321597045 endingPage "176" @default.
• W4321597045 startingPage "165" @default.
• W4321597045 abstract "Hepatic angiosarcoma (HAS) is an aggressive mesenchymal malignancy that remains underexplored with respect to its etiology and mutational landscapes. To clarify the association between HAS and end-stage renal disease (ESRD), we used nationwide data of the National Health Insurance Research Database (NHIRD) in Taiwan, covering ~99% of the population, from 2001 to 2016. To investigate molecular signatures, we performed whole-exome sequencing (WES) in 27 surgical specimens, including nine ESRD-associated cases. The NHIRD analysis demonstrated that HAS ranked second among all angiosarcomas in Taiwan, with the incidence rates of HAS being 0.08, 2.49, and 5.71 per 100,000 person-years in the general population, chronic kidney disease (CKD), and ESRD patients, respectively. The standardized incidence ratios of HAS in CKD and ESRD patients were 29.99 and 68.77, respectively. In comparison with nonhepatic angiosarcoma, the multivariate regression analysis of our institutional cohort confirmed CKD/ESRD as an independent risk factor for HAS (odds ratio: 9.521, 95% confidence interval: 2.995-30.261, p < 0.001). WES identified a high tumor mutation burden (TMB; median: 8.66 variants per megabase) and dominant A:T-to-T:A transversion in HAS with frequent TP53 (81%) and ATRX (41%) mutations, KDR amplifications/gains (56%), and CDKN2A/B deletions (48%). Notably, ESRD-associated HAS had a significantly higher TMB (17.62 variants per megabase, p = 0.01) and enriched mutational signatures of aristolochic acid exposure (COSMIC SBS22, p < 0.001). In summary, a significant proportion of HAS in Taiwan is associated with ESRD and harbors a distinctive mutational signature, which concomitantly links nephrotoxicity and mutagenesis resulting from exposure to aristolochic acid or related compounds. A high TMB may support the eligibility for immunotherapy in treating ESRD-associated HAS. © 2023 The Pathological Society of Great Britain and Ireland." @default.
• W4321597045 created "2023-02-24" @default.
• W4321597045 creator A5001390997 @default.
• W4321597045 creator A5002226964 @default.
• W4321597045 creator A5014424789 @default.
• W4321597045 creator A5022543698 @default.
• W4321597045 creator A5038535929 @default.
• W4321597045 creator A5054328117 @default.
• W4321597045 creator A5056561487 @default.
• W4321597045 creator A5057861986 @default.
• W4321597045 creator A5062176597 @default.
• W4321597045 creator A5063798048 @default.
• W4321597045 creator A5069344015 @default.
• W4321597045 creator A5070620970 @default.
• W4321597045 creator A5076863688 @default.
• W4321597045 date "2023-04-11" @default.
• W4321597045 modified "2023-10-18" @default.
• W4321597045 title "Association between hepatic angiosarcoma and end‐stage renal disease: nationwide population‐based evidence and enriched mutational signature of aristolochic acid exposure" @default.
• W4321597045 cites W1554955944 @default.
• W4321597045 cites W1877998958 @default.
• W4321597045 cites W1892696744 @default.
• W4321597045 cites W1983035953 @default.
• W4321597045 cites W1983986272 @default.
• W4321597045 cites W1984068087 @default.
• W4321597045 cites W1991209661 @default.
• W4321597045 cites W2023306589 @default.
• W4321597045 cites W2058024567 @default.
• W4321597045 cites W2082015504 @default.
• W4321597045 cites W2082312233 @default.
• W4321597045 cites W2089708180 @default.
• W4321597045 cites W2116612795 @default.
• W4321597045 cites W2117564738 @default.
• W4321597045 cites W2117785761 @default.
• W4321597045 cites W2119180969 @default.
• W4321597045 cites W2119657975 @default.
• W4321597045 cites W2129136620 @default.
• W4321597045 cites W2129218640 @default.
• W4321597045 cites W2146904754 @default.
• W4321597045 cites W2149441684 @default.
• W4321597045 cites W2152061559 @default.
• W4321597045 cites W2157852151 @default.
• W4321597045 cites W2161032069 @default.
• W4321597045 cites W2192124831 @default.
• W4321597045 cites W2203006988 @default.
• W4321597045 cites W2313763380 @default.
• W4321597045 cites W2319362041 @default.
• W4321597045 cites W2398904273 @default.
• W4321597045 cites W2509951725 @default.
• W4321597045 cites W2567051070 @default.
• W4321597045 cites W2611387862 @default.
• W4321597045 cites W2765243483 @default.
• W4321597045 cites W2765468373 @default.
• W4321597045 cites W2794211683 @default.
• W4321597045 cites W2800002600 @default.
• W4321597045 cites W2809783743 @default.
• W4321597045 cites W2894573839 @default.
• W4321597045 cites W2896872272 @default.
• W4321597045 cites W2900082702 @default.
• W4321597045 cites W2943005888 @default.
• W4321597045 cites W2945564879 @default.
• W4321597045 cites W2951319952 @default.
• W4321597045 cites W2963671541 @default.
• W4321597045 cites W3004480399 @default.
• W4321597045 cites W3005073090 @default.
• W4321597045 cites W3012921809 @default.
• W4321597045 cites W3021652710 @default.
• W4321597045 cites W3045031425 @default.
• W4321597045 cites W3047759655 @default.
• W4321597045 cites W3091042659 @default.
• W4321597045 cites W3099993684 @default.
• W4321597045 cites W3121747858 @default.
• W4321597045 cites W3137671123 @default.
• W4321597045 cites W3176706531 @default.
• W4321597045 cites W33617873 @default.
• W4321597045 cites W4210315151 @default.
• W4321597045 cites W4224263489 @default.
• W4321597045 cites W4241497580 @default.
• W4321597045 cites W4285797487 @default.
• W4321597045 doi "https://doi.org/10.1002/path.6072" @default.
• W4321597045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36815532" @default.
• W4321597045 hasPublicationYear "2023" @default.
• W4321597045 type Work @default.
• W4321597045 citedByCount "0" @default.
• W4321597045 crossrefType "journal-article" @default.
• W4321597045 hasAuthorship W4321597045A5001390997 @default.
• W4321597045 hasAuthorship W4321597045A5002226964 @default.
• W4321597045 hasAuthorship W4321597045A5014424789 @default.
• W4321597045 hasAuthorship W4321597045A5022543698 @default.
• W4321597045 hasAuthorship W4321597045A5038535929 @default.
• W4321597045 hasAuthorship W4321597045A5054328117 @default.
• W4321597045 hasAuthorship W4321597045A5056561487 @default.
• W4321597045 hasAuthorship W4321597045A5057861986 @default.
• W4321597045 hasAuthorship W4321597045A5062176597 @default.
• W4321597045 hasAuthorship W4321597045A5063798048 @default.
• W4321597045 hasAuthorship W4321597045A5069344015 @default.
• W4321597045 hasAuthorship W4321597045A5070620970 @default.
• W4321597045 hasAuthorship W4321597045A5076863688 @default.
• W4321597045 hasConcept C120665830 @default.

• next